Clinical Trial Update: Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the effectiveness and safety of amisulpride in Chinese patients with schizophrenia has been completed and results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Amisulpride (amisulpride)

Snippet

Sponsor: Sanofi | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED